Real-time Assessment of Community Transmission (REACT) Study 2: COVID antibody

REACT-2 is a large-scale national surveillance study in England. It examines the prevalence of antibodies to SARS-CoV-2 in adults the community. Participants complete finger prick self-testing at home (lateral flow immunoassay) and a questionnaire.

Webpage:
https://www.healthdatagateway.org/dataset/f9959c00-c063-4fbf-933d-755e3b6ecedc

Licence:
Name: HDR UK Innovation Gateway Access
URL: https://www.hdruk.ac.uk/infrastructure/gateway/terms-and-conditions/

Tags:

sars-cov-2 covid-19 antibody prevalence surveillance

More to explore:

1/20



Need help integrating and/or managing biomedical data?